1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
New Nordic Healthbrands AB

New Nordic Healthbrands AB

NNH.ST
New Nordic Healthbrands ABSE flagStockholm Stock Exchange
12.40
SEK
- -
- -
76.82MMarket Cap
New Nordic Healthbrands AB
NNH.ST
(Stockholm Stock Exchange)

Recent

price

12.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
31.53
32.2
32.89
36.8
43.9
48.18
49.37
55.65
63.55
73.06
72.65
83.1
78.69
86.17
88.83
93.03
91.36
Revenue per Share
-0.92
0.05
-0.66
0.93
2
1.83
1.55
3.28
4.28
4.53
2.87
3.44
-0.46
-1
-1.24
1.32
0.8
Basic EPS, GAAP
0.2
- -
0.53
- -
0.42
-0.54
-1.59
4.23
2.74
-0.38
2.87
-1.7
-2.97
4.03
-1.59
0.79
0.47
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
0.25
0.4
1.15
1.5
1.75
1.5
1.25
- -
- -
- -
- -
Dividend per Share
0.08
1.38
0.86
1.55
4.04
5.77
6.94
9.82
12.95
16.45
16.92
19.42
18.17
17.11
1
1
1
Book Value per Share
-1.32
-0.28
0.14
1.34
3.56
5.66
6.9
9.81
12.95
16.33
16.64
18.93
17.59
16.54
15.42
15.62
15.56
Tangible Book Value per Share
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
Basic Weighted Avg Shares
195
199
204
228
272
298
306
345
394
453
450
515
488
534
550
576
566
Sales/Revenue/Turnover
0.1
3.01
-0.51
4.02
5.96
5.27
4.25
8.02
8.69
8.02
5.3
5.55
-0.97
-0.59
-0.81
2.63
1.75
Operating Margin (%)
8
8
6
3
3
3
1
1
1
1
1
1
2
2
3
2
3
Depreciation Expense
-6
- -
-4
6
12
11
10
20
27
28
18
21
-3
-6
-8
8
5
Net Income, GAAP
- -
86.9
- -
26.77
25.11
20.44
23.55
25.14
22.26
22.16
23.73
23.8
- -
- -
- -
34.5
32.22
Effective Tax Rate (%)
-2.93
0.16
-2.01
2.54
4.55
3.8
3.13
5.89
6.74
6.2
3.95
4.14
-0.58
-1.16
-1.4
1.42
0.87
Profit Margin (%)
-12
-6
-6
2
14
31
39
59
78
99
103
114
100
90
80
84
83
Working Capital
5
1
1
1
1
1
1
1
1
2
- -
- -
- -
- -
2
2
2
LT Debt
11
12
8
14
25
36
43
61
80
102
105
120
113
106
101
103
102
Total Equity
- -
2.61
- -
29.72
39.35
26.37
14.95
28.25
33.56
27.33
15.93
16.91
- -
- -
- -
7
4.67
Return on Invested Capital (%)
- -
3.68
- -
43.69
49.19
26.97
15.88
29.08
34.91
28.69
16.52
17.33
- -
- -
- -
21.94
7.55
Return on Capital (%)
-150.86
6.89
-58.93
77.49
71.38
37.25
24.31
39.11
37.62
30.83
17.19
18.93
-2.42
-5.67
-13.72
132.28
9.77
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
37
37
35
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
93
86
121

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
226
228
231
Cash, Cash Equivalents & STI
15
8
10
Accounts Receivable, Net
88
94
96
Inventories
107
110
112
Total Current Liabilities
146
147
148
Payables & Accruals
- -
- -
- -
ST Debt
37
37
35
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.37%
0.05%
2.53%
Free Cash Flow
-178.79%
-121.87%
-149.99%
Net Income, GAAP
-5.98%
-31.21%
-206.44%
Sales/Revenue/Turnover
7.02%
5.28%
4.73%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130
141
130
150
550
2025
144
143
151
- -
576
2026
132
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.55
-0.72
-0.28
0.31
-1.24
2025
0.43
0.34
0.33
- -
1.32
2026
-0.46
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Neurogenesis, Inc. (NEUN)
Cian Healthcare Limited (CHCL.BO)
PharmaResearch Co., Ltd. (214450.KQ)
Unity Biotechnology, Inc. (0YC0.L)
Qomel Company Limited (9600.SR)
Royalty Pharma plc (RPRX)
Business
New Nordic Healthbrands AB (publ) (NNH.ST) develops, markets, and sells dietary supplements, herbal pharmaceuticals, natural medicines, and personal care products targeting specific health and beauty concerns including diet, vitality, sleep, anti-ageing, hair, skin, nails, immune support, vision, and liver health; core brands and product lines encompass Apple Cider, BioFirm, Chili Burn, Blue Berry, Frutin, Active Liver, dida, Hair Volume, Nail Strong, and Skin Care. Products utilize natural ingredients such as herbal extracts, vitamins, micronutrients, and fatty acids, sold through retailers in over 44 countries with primary operations in the Nordic region, rest of Europe including strong growth in England, Ireland, and Germany, and other international markets. Founded in 1990 and headquartered in Malmö, Sweden at Hyllie Boulevard 34, the company lists on Nasdaq First North Growth Market Sweden since 2007 and employs approximately 73 people. Recent developments include reporting revenue growth of 10% in Q1 2025 continuing positive Q4 2024 momentum with successful new product launches and enhanced retail collaborations particularly in England and Ireland; issuance of the 2024 full year and annual reports alongside six-month and nine-month 2024 reports reflecting directional improvement; communication from the 2025 annual general meeting and nomination committee proposals for the board; and launch of new brand Kunkeei Beauty Liquid as part of ongoing innovation.